HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilio Bajetta Selected Research

EAP protocol

10/2013Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilio Bajetta Research Topics

Disease

31Neoplasms (Cancer)
01/2018 - 01/2002
14Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 03/2003
14Breast Neoplasms (Breast Cancer)
01/2019 - 01/2002
14Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 01/2004
10Disease Progression
01/2022 - 01/2002
8Renal Cell Carcinoma (Grawitz Tumor)
10/2011 - 01/2007
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2011 - 06/2003
6Adenocarcinoma
08/2016 - 12/2002
6Stomach Neoplasms (Stomach Cancer)
08/2016 - 12/2002
6Nausea
02/2013 - 01/2002
5Vomiting
02/2013 - 07/2008
4Melanoma (Melanoma, Malignant)
10/2013 - 10/2002
4Carcinoma (Carcinomatosis)
12/2012 - 11/2004
4Pancreatic Neoplasms (Pancreatic Cancer)
08/2008 - 06/2007
4Fatigue
06/2008 - 09/2004
3Neoplasm Metastasis (Metastasis)
01/2018 - 04/2016
3Colonic Neoplasms (Colon Cancer)
12/2012 - 05/2008
2Hypertension (High Blood Pressure)
01/2019 - 12/2012
2Primitive Neuroectodermal Tumors (PNET)
01/2018 - 01/2014
2Carcinoid Tumor (Carcinoid)
12/2015 - 07/2010
2Exanthema (Rash)
01/2013 - 05/2009
2Prostatic Neoplasms (Prostate Cancer)
07/2011 - 11/2004
2Malignant Mesothelioma
11/2010 - 05/2010
2Abdominal Pain (Pain, Abdominal)
06/2008 - 01/2002
2Asthenia
06/2008 - 12/2007
2Anemia
10/2004 - 09/2004
1Dyslipidemias (Dyslipidemia)
01/2019
1Osteoporosis
01/2019
1Arthralgia (Joint Pain)
01/2019
1Triple Negative Breast Neoplasms
01/2018
1Hyperglycemia
01/2018

Drug/Important Bio-Agent (IBA)

11Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2015 - 01/2004
10Irinotecan (Camptosar)FDA LinkGeneric
04/2016 - 01/2004
10Capecitabine (Xeloda)FDA Link
03/2015 - 01/2004
9Bevacizumab (Avastin)FDA Link
03/2015 - 12/2007
8Cisplatin (Platino)FDA LinkGeneric
08/2016 - 06/2003
7EverolimusFDA Link
01/2018 - 06/2011
7Fluorouracil (Carac)FDA LinkGeneric
08/2016 - 01/2004
7Biological ProductsIBA
02/2011 - 10/2002
6Octreotide (Sandostatin)FDA LinkGeneric
01/2018 - 01/2002
6Leucovorin (Folinic Acid)FDA Link
04/2016 - 01/2004
6GemcitabineFDA Link
11/2010 - 02/2004
5Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 01/2002
5Palonosetron (Aloxi)FDA Link
02/2013 - 07/2008
4Docetaxel (Taxotere)FDA Link
08/2016 - 01/2006
4AntiemeticsIBA
02/2013 - 07/2008
4Dexamethasone (Maxidex)FDA LinkGeneric
02/2013 - 07/2008
4Pharmaceutical PreparationsIBA
05/2010 - 01/2002
4PlatinumIBA
05/2009 - 02/2004
4Hormones (Hormone)IBA
12/2004 - 05/2003
4TamoxifenFDA LinkGeneric
05/2004 - 01/2002
3Aromatase InhibitorsIBA
01/2019 - 05/2003
3Biomarkers (Surrogate Marker)IBA
04/2016 - 07/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2014 - 12/2007
3Sorafenib (BAY 43-9006)FDA Link
10/2011 - 01/2007
3Carboplatin (JM8)FDA LinkGeneric
07/2011 - 06/2003
3Estrogens (Estrogen)FDA Link
07/2009 - 05/2004
3Estrogen ReceptorsIBA
06/2008 - 03/2004
3Interferon-alpha (Interferon Alfa)IBA
01/2008 - 10/2003
3exemestane (Aromasin)FDA Link
03/2004 - 05/2003
2lanreotide (Somatuline)FDA Link
01/2018 - 11/2006
2Hemoglobins (Hemoglobin)IBA
01/2018 - 09/2004
2Cetuximab (Erbitux)FDA Link
01/2017 - 05/2009
2XELOXIBA
12/2014 - 12/2012
2CytokinesIBA
08/2014 - 08/2007
2Sunitinib (Sutent)FDA Link
10/2011 - 01/2009
2Paclitaxel (Taxol)FDA LinkGeneric
07/2011 - 06/2003
2Angiogenesis InhibitorsIBA
05/2011 - 02/2011
2Pemetrexed (MTA)FDA Link
11/2010 - 12/2002
2Interferon alpha-2 (Roferon-A)FDA Link
05/2010 - 12/2007
2Monoclonal AntibodiesIBA
05/2009 - 08/2007
2ErbB Receptors (EGF Receptor)IBA
05/2009 - 08/2007
2Toremifene (Fareston)FDA Link
06/2008 - 12/2004
2Estrogen Receptor Modulators (Antiestrogen)IBA
12/2004 - 05/2004
2AndrogensIBA
11/2004 - 05/2004
2Epoetin Alfa (Epogen)FDA Link
10/2004 - 09/2004
2Aminoglutethimide (Cytadren)FDA Link
05/2004 - 05/2003
2Aromatase (CYP19)IBA
05/2004 - 07/2003
2Anastrozole (Arimidex)FDA LinkGeneric
05/2004 - 05/2003
2Letrozole (Femara)FDA LinkGeneric
05/2004 - 05/2003
2thiamine triphosphorate (TTP)IBA
05/2004 - 01/2002
2Insulin-Like PeptidesIBA
07/2003 - 05/2003
1Peptide Receptors (Peptide Receptor)IBA
01/2022
1Radioisotopes (Radionuclides)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Metformin (Glucophage)FDA LinkGeneric
01/2018
1eribulinFDA Link
01/2018
1trans-sodium crocetinate (crocetin)IBA
08/2016
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2016
1CateninsIBA
04/2016
1Cadherins (E-Cadherin)IBA
04/2016
1OsteopontinIBA
04/2016

Therapy/Procedure

25Drug Therapy (Chemotherapy)
01/2022 - 01/2002
20Therapeutics
01/2022 - 01/2002
4Adjuvant Chemotherapy
08/2016 - 07/2011
4Radiotherapy
12/2014 - 01/2002
3Aftercare (After-Treatment)
01/2022 - 12/2004
3Biological Therapy
03/2007 - 03/2003
1Radiofrequency Ablation
01/2017
1Hepatectomy
01/2017